ホーム › 尿路上皮（移行上皮）癌 › ノースカロライナ
ノースカロライナにおける尿路上皮（移行上皮）癌の臨床試験
ノースカロライナ内の拠点で、尿路上皮（移行上皮）癌に関する15件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- Margaret R Pardee Memorial Hospital, Hendersonville
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06524544A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Carolina Cancer Research Center, Wilson
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #12, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Margaret R Pardee Memorial Hospital, Hendersonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- The University of North Carolina Chapel Hill, Chapel Hill
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/29更新 · NCT05874921Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Duke Cancer Center Cary, Cary
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- 他5件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07421700A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Levine Cancer Institute, Charlotte
- Oncology Specialists of Charlotte, Charlotte
- Wake Forest Baptist Health, Winston-Salem
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- Carolina Biooncology Institute, Huntersville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT04977453A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- Urology Specialists of the Carolinas, PLLC, Charlotte
- Urology Specialists of the Carolinas - Greensboro, Greensboro
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06774131Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Chapel Hill
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07129993A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, Huntersville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/06更新 · NCT07749586A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill
- Carolinas Medical Center (biopsy only), Charlotte
- 他10件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/22更新 · NCT04879329A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Huntersville
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/07更新 · NCT06999187SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study of NX-1607 in Adults With Advanced Malignancies
- University of North Carolina, Chapel Hill
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/09更新 · NCT05107674ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。